Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

  • What Is Cancer Nanotechnology

    What Is Cancer Nanotechnology

    Cancer nanotechnology has the potential to dramatically improve current approach

    2025-03-18 19
  • Analysis of Cyclin-Dependent Kinase Activity

    Analysis of Cyclin-Dependent Kinase Activity

    The number of kinases, enzymes whose purpose is to phosphorylate other proteins

    2025-03-18 25
  • Use of Nucleotide Excision Repair-Deficient Mice as a Model For Chemically Induced Lung Cancer

    Use of Nucleotide Excision Repair-Deficient Mice as a Model For Chemically Induced Lung Cancer

    The combination of classical mouse genetics with mouse models derived from trans

    2025-03-18 23
  • Deletion of the Derivative Chromosome 9 in Chronic Myeloid Leukemia

    Deletion of the Derivative Chromosome 9 in Chronic Myeloid Leukemia

    With the development of fluorescence in situ hybridization (FISH), it was possib

    2025-03-18 18
  • Prostate Epithelial Stem Cell Isolation and Culture

    Prostate Epithelial Stem Cell Isolation and Culture

    Although epithelial stem cells are implicated in the etiology of both benign pro

    2025-03-18 21
  • Chemotherapy-Inducible Vector for Gene Therapy of Cancer

    Chemotherapy-Inducible Vector for Gene Therapy of Cancer

    A great variety of viral and nonviral expression systems has been developed and

    2025-03-18 19
  • The NF-B Transcription Factor Pathway as a Therapeutic Target in Cancer: Methods for Detection of NF

    The NF-B Transcription Factor Pathway as a Therapeutic Target in Cancer: Methods for Detection of NF

    NF-κB transcription factors marshal innate and adaptive immunity and inflammatio

    2025-03-18 21
  • Diagnosis and Monitoring of PML-RARA-Positive Acute Promyelocytic Leukemia by Qualitative RT-PCR

    Diagnosis and Monitoring of PML-RARA-Positive Acute Promyelocytic Leukemia by Qualitative RT-PCR

    The t(15;17) is the diagnostic hallmark of acute promyelocytic leukemia (APL). A

    2025-03-18 25
  • Racial Differences in Clinical Outcome After Prostate Cancer Treatment

    Racial Differences in Clinical Outcome After Prostate Cancer Treatment

    Prostate cancer is the number one killer in the United States. A comparison of U

    2025-03-18 19
  • Lectin Histochemistry to Detect Altered Glycosylation in Cells and Tissues

    Lectin Histochemistry to Detect Altered Glycosylation in Cells and Tissues

    A lectin is “a protein or glycoprotein of non-immune origin, not an enzyme, that

    2025-03-18 15
  • In Vivo Models of Human Prostate Cancer Bone Metastasis

    In Vivo Models of Human Prostate Cancer Bone Metastasis

    According to the American Cancer Society, adenocarcinoma of the prostate is the

    2025-03-18 19
  • Thriving for Clues in Variations Seen in Mortality and Incidence of Cancer: Geographic Patterns, Tem

    Thriving for Clues in Variations Seen in Mortality and Incidence of Cancer: Geographic Patterns, Tem

    To address the diverse features of the cancer epidemic, scientists have continua

    2025-03-18 19
  • Spontaneous and Experimental Metastasis Models: Nude Mice

    Spontaneous and Experimental Metastasis Models: Nude Mice

    Immunodeficient mice are widely used for cancer research as they can provide an

    2025-03-18 20
  • Analysis of Nuclear and Cytoplasmic Degradation of p53 in Cells after Stress

    Analysis of Nuclear and Cytoplasmic Degradation of p53 in Cells after Stress

    Until recently, the accepted model held that p53 degradation occurs exclusively

    2025-03-18 19
  • The Epidemiology of Ovarian Cancer

    The Epidemiology of Ovarian Cancer

    Ovarian cancer is the most common fatal cancer of the female reproductive tract

    2025-03-18 25